BioWorld Asia

July 6, 2006

View Archived Issues

Nicotine Receptor Discovery Could Help Treat Addiction

Read More

Diatos IPO Would Raise €25M, Sell Quarter Of Firm To Public

No Abstract Read More

Negative European Opinion Given For New Biogeneric

Read More

MediGene Shares Slide On FDA PDUFA Date Extension

Read More

New Institute Being Built To Focus On Oxford Research

Read More

Vectura Gets £45M, Reports Trial Data For Two Products

Read More

Cellectis, Bayer CropScience Working On Plant Technology

Read More

Other News To Note

Read More

Medivir Could Earn $111M Through New Tibotec Deals

Medivir AB could earn about $111 million in up-front and milestone payments from two new drug development licensing deals with Tibotec Pharmaceuticals Ltd. (BioWorld International) Read More

Unable To Attract Funding, TeGenero Going Belly Up

Read More